The Recall Desk
HighFDA (Devices)·Z-0489-2026·Announced 2025-11-19

Hematology analyzers recalled because saturation flags may not be applied

Abbott Laboratories is recalling 833 Alinity hq Analyzers because a software issue means the system does not visibly flag results when saturation is present, which may give incorrect results.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: Scored 3 under the risk-of-harm criterion: results that should be flagged as suspect can be reported as valid, and no injuries are reported.

Plain-English summary

The Abbott Alinity hq Analyzer, model 09P68-01, is being recalled across software versions 5.0 to 5.10.1 outside the United States and 5.7 and 5.10.1 in the United States.

A software issue for the hq analyzer results in the system not visibly applying appropriate flagging to results when saturation is present, which may result in incorrect results.

The recall covers 833 units, distributed worldwide including in Alabama, California, Colorado, Florida, Indiana, Minnesota, North Carolina, New York and Oklahoma. The FDA has classified the action as Class II.

A missing flag means a result that should be treated as suspect can be reported as if it were valid. Laboratories running an affected version should follow Abbott's instructions.

The recalled product

Product
Brand Name: Alinity hq Analyzer Product Name: Alinity hq Analyzer Model/Catalog Number: 09P68-01 Software Version: 5.0 to 5.10.1 for OUS, 5.7 and 5.10.1 in the US Product Description: Alinity hq Analyzer Component: No
Affected units
833

Distribution

Distributed nationwide across the United States.

The notice also names 9 states specifically: